Enrico PIERANTOZZI

Dr. Enrico PIERANTOZZI

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2007 in Oncogene
Verified
Journal Article
Closed access
RBR Busà
R Busà
MPMaria Paola Paronetto
Maria Paola Paronetto
DFDonatella Farini
Donatella Farini
EPEnrico PIERANTOZZI
Enrico PIERANTOZZI
FBF Botti
F Botti
CSClaudio Sette
Claudio Sette

29 September 2010 in Stem Cells and Development
Verified
Journal Article
Closed access
EPEnrico PIERANTOZZI
Enrico PIERANTOZZI
BGBarbara Gava
Barbara Gava
IMIvana Manini
Ivana Manini
FRFranco Roviello
Franco Roviello
GMGiuseppe Marotta
Giuseppe Marotta
Vincenzo SorrentinoVincenzo Sorrentino
Vincenzo Sorrentino
Mesenchymal stem cells (MSCs) are adult multipotent cells able to differentiate toward mature mesodermal lineages. In spite of more than a decade of investigation, little is known about the molecular mechanisms regulating the undifferentiated state and the identity of distinct functional subpopulations in these cells. Transcription factors that regulate the maintenance of the pluripotent state in embryonic stem cells, including NANOG, SOX2, and OCT4, have been proposed to play a similar role also in adult stem cells, although with conflicting results. We performed a critical evaluation of expression of these 3 transcription factors and found that NANOG, but not OCT-4 and SOX-2, is expressed in cultured human adult MSCs. Actually, NANOG was not expressed in freshly isolated MSCs, but was detected only after in vitro culture. NANOG was detected only in proliferating cells, but not in MSCs induced to differentiate. The percentage of cells expressing NANOG was maintained throughout early passages of MSCs, but then started to decrease in late passages in MSCs from adipose tissue and heart but not from bone marrow. However, the number of NANOG-expressing cells did not associate with the proliferative and differentiative capabilities of MSC populations, neither its expression appeared to identify cells having stem or progenitor cell properties. Accordingly, we propose that activation of NANOG expression in MSCs is associated with, although cannot directly regulate, the transition from in vivo quiescence to adaptation to in vitro growth conditions.

18 February 2013 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
DRDavide Randazzo
Davide Randazzo
EGEmiliana Giacomello
Emiliana Giacomello
SLStefania Lorenzini
Stefania Lorenzini
DRDaniela Rossi
Daniela Rossi
EPEnrico PIERANTOZZI
Enrico PIERANTOZZI
Vincenzo SorrentinoVincenzo Sorrentino
Vincenzo Sorrentino
Obscurin is a large myofibrillar protein that contains several interacting modules, one of which mediates binding to muscle-specific ankyrins. Interaction between obscurin and the muscle-specific ankyrin sAnk1.5 regulates the organization of the sarcoplasmic reticulum in striated muscles. Additional muscle-specific ankyrin isoforms, ankB and ankG, are localized at the subsarcolemma level, at which they contribute to the organization of dystrophin and β-dystroglycan at costameres. In this paper, we report that in mice deficient for obscurin, ankB was displaced from its localization at the M band, whereas localization of ankG at the Z disk was not affected. In obscurin KO mice, localization at costameres of dystrophin, but not of β-dystroglycan, was altered, and the subsarcolemma microtubule cytoskeleton was disrupted. In addition, these mutant mice displayed marked sarcolemmal fragility and reduced muscle exercise tolerance. Altogether, the results support a model in which obscurin, by targeting ankB at the M band, contributes to the organization of subsarcolemma microtubules, localization of dystrophin at costameres, and maintenance of sarcolemmal integrity.

12 August 2014 in Human Mutation
Verified
Journal Article
Closed access
PDF file
DRDaniela Rossi
Daniela Rossi
Bianca VezzaniBianca Vezzani
Bianca Vezzani
LGLucia Galli
Lucia Galli
CPCecilia Paolini
Cecilia Paolini
LTLuana Toniolo
Luana Toniolo
Vincenzo SorrentinoVincenzo Sorrentino
Vincenzo Sorrentino

11 September 2017 in Human Mutation
Verified
Journal Article
Closed access
PDF file
VBVirginia Barone
Virginia Barone
VRValeria Del Re
Valeria Del Re
AGAlessandra Gamberucci
Alessandra Gamberucci
VPValentina Polverino
Valentina Polverino
LGLucia Galli
Lucia Galli
Vincenzo SorrentinoVincenzo Sorrentino
Vincenzo Sorrentino

23 March 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
DRDaniela Rossi
Daniela Rossi
EPEnrico PIERANTOZZI
Enrico PIERANTOZZI
DADavid Osamwonuyi Amadsun
David Osamwonuyi Amadsun
SBSara Buonocore
Sara Buonocore
EREgidio Maria Rubino
Egidio Maria Rubino
Vincenzo SorrentinoVincenzo Sorrentino
Vincenzo Sorrentino
The sarcoplasmic reticulum of skeletal muscle cells is a highly ordered structure consisting of an intricate network of tubules and cisternae specialized for regulating Ca2+ homeostasis in the context of muscle contraction. The sarcoplasmic reticulum contains several proteins, some of which support Ca2+ storage and release, while others regulate the formation and maintenance of this highly convoluted organelle and mediate the interaction with other components of the muscle fiber. In this review, some of the main issues concerning the biology of the sarcoplasmic reticulum will be described and discussed; particular attention will be addressed to the structure and function of the two domains of the sarcoplasmic reticulum supporting the excitation–contraction coupling and Ca2+-uptake mechanisms.